Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ADADRXthis companyADARx Pharmaceuticals, Inc.	$13.61	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
ARCTArcturus Therapeutics Holdings Inc.	$10.42	-2.55×	0.78×	2.5×	0.61×	-144.1%	95.5%	-111.5%	-97.9%	-30.7%	-31.4%	-44.2%	0.12×	3.28×	0×	6.64×	0.0%	1	-0.72	2	C
BNTCBenitec Biopharma Inc.	$9.31	-13.65×	3.52×	0×	-8.75×	-68.5%	0.0%	0.0%	0.0%	-25.7%	-28.8%	-2.7%	0×	3.53×	0×	34×	0.0%	1	43.49	2	C+
MGTXMeiraGTx Holdings plc	$9.34	-5.6×	-110.38×	7.86×	-7.4×	-554.4%	94.0%	-130.2%	-140.3%	1971.4%	-70.9%	-7.8%	-15.31×	-0.25×	-8.69×	0.75×	0.0%	6	4.07	3	B
PRMEPrime Medicine, Inc.	$4.32	-2.57×	4.27×	111.44×	-2.91×	-102.2%	-58.1%	-4498.1%	-4342.4%	-166.4%	-66.5%	-32.4%	0.96×	-0.27×	0×	4.84×	0.0%	2	-5.36	1	D+
RNAAtrium Therapeutics, Inc.	$8.30	-3.29×	1.22×	13.56×	0.18×	-203.3%	100.0%	-412.6%	-411.9%	-37.0%	-31.9%	-16.9%	0.02×	3.48×	0×	6.53×	0.0%	—	—	2	C+
Peer median	—	-3.29×	1.22×	7.86×	-2.91×	-144.1%	94.0%	-130.2%	-140.3%	-30.7%	-31.9%	-16.9%	0.02×	3.28×	0×	6.53×	0.0%	2	1.67	2	—